This report contains market size and forecasts of Anti-infectious Disease Drugs in global, including the following market information:
- Global Anti-infectious Disease Drugs Market Revenue, 2018-2023, 2023-2030, ($ millions)
- Global Anti-infectious Disease Drugs Market Sales, 2018-2023, 2023-2030, (K Units)
Global top five Anti-infectious Disease Drugs companies in 2022 (%)
The global Anti-infectious Disease Drugs market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Antibacterial Drugs Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Anti-infectious Disease Drugs include Aridis Pharmaceuticals, AiCuris, Sandoz, Anhui Jingfang Medical Industry Co.,Ltd, Beijing Double-Crane Pharmaceutical Co., Ltd., Abbott, Spero Therapeutics, Adlyfe, Inc. and Advanced Life Sciences Holdings, Inc., etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti-infectious Disease Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-infectious Disease Drugs Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Anti-infectious Disease Drugs Market Segment Percentages, by Type, 2022 (%)
- Antibacterial Drugs
- Antifungal Drugs
- Antiviral Drugs
- Antiparasitic Drugs
Global Anti-infectious Disease Drugs Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Anti-infectious Disease Drugs Market Segment Percentages, by Application, 2022 (%)
- Hospital
- Institute of Medicine
- Clinic
- Others
Global Anti-infectious Disease Drugs Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Anti-infectious Disease Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Anti-infectious Disease Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Anti-infectious Disease Drugs revenues share in global market, 2022 (%)
- Key companies Anti-infectious Disease Drugs sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies Anti-infectious Disease Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Aridis Pharmaceuticals
- AiCuris
- Sandoz
- Anhui Jingfang Medical Industry Co.,Ltd
- Beijing Double-Crane Pharmaceutical Co., Ltd.
- Abbott
- Spero Therapeutics
- Adlyfe, Inc.
- Advanced Life Sciences Holdings, Inc.
- Affinium Pharmaceuticals
- APP Pharmaceuticals
- Aquapharm Biodiscovery
- Basilea Pharmaceutica AG
- Biophage Pharma, Inc.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti-infectious Disease Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-infectious Disease Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-infectious Disease Drugs Overall Market Size
2.1 Global Anti-infectious Disease Drugs Market Size: 2022 VS 2030
2.2 Global Anti-infectious Disease Drugs Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Anti-infectious Disease Drugs Sales: 2018-2030
3 Company Landscape
3.1 Top Anti-infectious Disease Drugs Players in Global Market
3.2 Top Global Anti-infectious Disease Drugs Companies Ranked by Revenue
3.3 Global Anti-infectious Disease Drugs Revenue by Companies
3.4 Global Anti-infectious Disease Drugs Sales by Companies
3.5 Global Anti-infectious Disease Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Anti-infectious Disease Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Anti-infectious Disease Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-infectious Disease Drugs Players in Global Market
3.8.1 List of Global Tier 1 Anti-infectious Disease Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-infectious Disease Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-infectious Disease Drugs Market Size Markets, 2022 & 2030
4.1.2 Antibacterial Drugs
4.1.3 Antifungal Drugs
4.1.4 Antiviral Drugs
4.1.5 Antiparasitic Drugs
4.2 By Type - Global Anti-infectious Disease Drugs Revenue & Forecasts
4.2.1 By Type - Global Anti-infectious Disease Drugs Revenue, 2018-2023
4.2.2 By Type - Global Anti-infectious Disease Drugs Revenue, 2023-2030
4.2.3 By Type - Global Anti-infectious Disease Drugs Revenue Market Share, 2018-2030
4.3 By Type - Global Anti-infectious Disease Drugs Sales & Forecasts
4.3.1 By Type - Global Anti-infectious Disease Drugs Sales, 2018-2023
4.3.2 By Type - Global Anti-infectious Disease Drugs Sales, 2023-2030
4.3.3 By Type - Global Anti-infectious Disease Drugs Sales Market Share, 2018-2030
4.4 By Type - Global Anti-infectious Disease Drugs Price (Manufacturers Selling Prices), 2018-2030
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Anti-infectious Disease Drugs Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Institute of Medicine
5.1.4 Clinic
5.1.5 Others
5.2 By Application - Global Anti-infectious Disease Drugs Revenue & Forecasts
5.2.1 By Application - Global Anti-infectious Disease Drugs Revenue, 2018-2023
5.2.2 By Application - Global Anti-infectious Disease Drugs Revenue, 2023-2030
5.2.3 By Application - Global Anti-infectious Disease Drugs Revenue Market Share, 2018-2030
5.3 By Application - Global Anti-infectious Disease Drugs Sales & Forecasts
5.3.1 By Application - Global Anti-infectious Disease Drugs Sales, 2018-2023
5.3.2 By Application - Global Anti-infectious Disease Drugs Sales, 2023-2030
5.3.3 By Application - Global Anti-infectious Disease Drugs Sales Market Share, 2018-2030
5.4 By Application - Global Anti-infectious Disease Drugs Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Anti-infectious Disease Drugs Market Size, 2022 & 2030
6.2 By Region - Global Anti-infectious Disease Drugs Revenue & Forecasts
6.2.1 By Region - Global Anti-infectious Disease Drugs Revenue, 2018-2023
6.2.2 By Region - Global Anti-infectious Disease Drugs Revenue, 2023-2030
6.2.3 By Region - Global Anti-infectious Disease Drugs Revenue Market Share, 2018-2030
6.3 By Region - Global Anti-infectious Disease Drugs Sales & Forecasts
6.3.1 By Region - Global Anti-infectious Disease Drugs Sales, 2018-2023
6.3.2 By Region - Global Anti-infectious Disease Drugs Sales, 2023-2030
6.3.3 By Region - Global Anti-infectious Disease Drugs Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Anti-infectious Disease Drugs Revenue, 2018-2030
6.4.2 By Country - North America Anti-infectious Disease Drugs Sales, 2018-2030
6.4.3 US Anti-infectious Disease Drugs Market Size, 2018-2030
6.4.4 Canada Anti-infectious Disease Drugs Market Size, 2018-2030
6.4.5 Mexico Anti-infectious Disease Drugs Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Anti-infectious Disease Drugs Revenue, 2018-2030
6.5.2 By Country - Europe Anti-infectious Disease Drugs Sales, 2018-2030
6.5.3 Germany Anti-infectious Disease Drugs Market Size, 2018-2030
6.5.4 France Anti-infectious Disease Drugs Market Size, 2018-2030
6.5.5 U.K. Anti-infectious Disease Drugs Market Size, 2018-2030
6.5.6 Italy Anti-infectious Disease Drugs Market Size, 2018-2030
6.5.7 Russia Anti-infectious Disease Drugs Market Size, 2018-2030
6.5.8 Nordic Countries Anti-infectious Disease Drugs Market Size, 2018-2030
6.5.9 Benelux Anti-infectious Disease Drugs Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Anti-infectious Disease Drugs Revenue, 2018-2030
6.6.2 By Region - Asia Anti-infectious Disease Drugs Sales, 2018-2030
6.6.3 China Anti-infectious Disease Drugs Market Size, 2018-2030
6.6.4 Japan Anti-infectious Disease Drugs Market Size, 2018-2030
6.6.5 South Korea Anti-infectious Disease Drugs Market Size, 2018-2030
6.6.6 Southeast Asia Anti-infectious Disease Drugs Market Size, 2018-2030
6.6.7 India Anti-infectious Disease Drugs Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Anti-infectious Disease Drugs Revenue, 2018-2030
6.7.2 By Country - South America Anti-infectious Disease Drugs Sales, 2018-2030
6.7.3 Brazil Anti-infectious Disease Drugs Market Size, 2018-2030
6.7.4 Argentina Anti-infectious Disease Drugs Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anti-infectious Disease Drugs Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Anti-infectious Disease Drugs Sales, 2018-2030
6.8.3 Turkey Anti-infectious Disease Drugs Market Size, 2018-2030
6.8.4 Israel Anti-infectious Disease Drugs Market Size, 2018-2030
6.8.5 Saudi Arabia Anti-infectious Disease Drugs Market Size, 2018-2030
6.8.6 UAE Anti-infectious Disease Drugs Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Aridis Pharmaceuticals
7.1.1 Aridis Pharmaceuticals Corporate Summary
7.1.2 Aridis Pharmaceuticals Business Overview
7.1.3 Aridis Pharmaceuticals Anti-infectious Disease Drugs Major Product Offerings
7.1.4 Aridis Pharmaceuticals Anti-infectious Disease Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Aridis Pharmaceuticals Key News
7.2 AiCuris
7.2.1 AiCuris Corporate Summary
7.2.2 AiCuris Business Overview
7.2.3 AiCuris Anti-infectious Disease Drugs Major Product Offerings
7.2.4 AiCuris Anti-infectious Disease Drugs Sales and Revenue in Global (2018-2023)
7.2.5 AiCuris Key News
7.3 Sandoz
7.3.1 Sandoz Corporate Summary
7.3.2 Sandoz Business Overview
7.3.3 Sandoz Anti-infectious Disease Drugs Major Product Offerings
7.3.4 Sandoz Anti-infectious Disease Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Sandoz Key News
7.4 Anhui Jingfang Medical Industry Co.,Ltd
7.4.1 Anhui Jingfang Medical Industry Co.,Ltd Corporate Summary
7.4.2 Anhui Jingfang Medical Industry Co.,Ltd Business Overview
7.4.3 Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Major Product Offerings
7.4.4 Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Anhui Jingfang Medical Industry Co.,Ltd Key News
7.5 Beijing Double-Crane Pharmaceutical Co., Ltd.
7.5.1 Beijing Double-Crane Pharmaceutical Co., Ltd. Corporate Summary
7.5.2 Beijing Double-Crane Pharmaceutical Co., Ltd. Business Overview
7.5.3 Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Major Product Offerings
7.5.4 Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Beijing Double-Crane Pharmaceutical Co., Ltd. Key News
7.6 Abbott
7.6.1 Abbott Corporate Summary
7.6.2 Abbott Business Overview
7.6.3 Abbott Anti-infectious Disease Drugs Major Product Offerings
7.6.4 Abbott Anti-infectious Disease Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Abbott Key News
7.7 Spero Therapeutics
7.7.1 Spero Therapeutics Corporate Summary
7.7.2 Spero Therapeutics Business Overview
7.7.3 Spero Therapeutics Anti-infectious Disease Drugs Major Product Offerings
7.7.4 Spero Therapeutics Anti-infectious Disease Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Spero Therapeutics Key News
7.8 Adlyfe, Inc.
7.8.1 Adlyfe, Inc. Corporate Summary
7.8.2 Adlyfe, Inc. Business Overview
7.8.3 Adlyfe, Inc. Anti-infectious Disease Drugs Major Product Offerings
7.8.4 Adlyfe, Inc. Anti-infectious Disease Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Adlyfe, Inc. Key News
7.9 Advanced Life Sciences Holdings, Inc.
7.9.1 Advanced Life Sciences Holdings, Inc. Corporate Summary
7.9.2 Advanced Life Sciences Holdings, Inc. Business Overview
7.9.3 Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Major Product Offerings
7.9.4 Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Advanced Life Sciences Holdings, Inc. Key News
7.10 Affinium Pharmaceuticals
7.10.1 Affinium Pharmaceuticals Corporate Summary
7.10.2 Affinium Pharmaceuticals Business Overview
7.10.3 Affinium Pharmaceuticals Anti-infectious Disease Drugs Major Product Offerings
7.10.4 Affinium Pharmaceuticals Anti-infectious Disease Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Affinium Pharmaceuticals Key News
7.11 APP Pharmaceuticals
7.11.1 APP Pharmaceuticals Corporate Summary
7.11.2 APP Pharmaceuticals Anti-infectious Disease Drugs Business Overview
7.11.3 APP Pharmaceuticals Anti-infectious Disease Drugs Major Product Offerings
7.11.4 APP Pharmaceuticals Anti-infectious Disease Drugs Sales and Revenue in Global (2018-2023)
7.11.5 APP Pharmaceuticals Key News
7.12 Aquapharm Biodiscovery
7.12.1 Aquapharm Biodiscovery Corporate Summary
7.12.2 Aquapharm Biodiscovery Anti-infectious Disease Drugs Business Overview
7.12.3 Aquapharm Biodiscovery Anti-infectious Disease Drugs Major Product Offerings
7.12.4 Aquapharm Biodiscovery Anti-infectious Disease Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Aquapharm Biodiscovery Key News
7.13 Basilea Pharmaceutica AG
7.13.1 Basilea Pharmaceutica AG Corporate Summary
7.13.2 Basilea Pharmaceutica AG Anti-infectious Disease Drugs Business Overview
7.13.3 Basilea Pharmaceutica AG Anti-infectious Disease Drugs Major Product Offerings
7.13.4 Basilea Pharmaceutica AG Anti-infectious Disease Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Basilea Pharmaceutica AG Key News
7.14 Biophage Pharma, Inc.
7.14.1 Biophage Pharma, Inc. Corporate Summary
7.14.2 Biophage Pharma, Inc. Business Overview
7.14.3 Biophage Pharma, Inc. Anti-infectious Disease Drugs Major Product Offerings
7.14.4 Biophage Pharma, Inc. Anti-infectious Disease Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Biophage Pharma, Inc. Key News
8 Global Anti-infectious Disease Drugs Production Capacity, Analysis
8.1 Global Anti-infectious Disease Drugs Production Capacity, 2018-2030
8.2 Anti-infectious Disease Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-infectious Disease Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-infectious Disease Drugs Supply Chain Analysis
10.1 Anti-infectious Disease Drugs Industry Value Chain
10.2 Anti-infectious Disease Drugs Upstream Market
10.3 Anti-infectious Disease Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-infectious Disease Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Anti-infectious Disease Drugs in Global Market
Table 2. Top Anti-infectious Disease Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Anti-infectious Disease Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Anti-infectious Disease Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Anti-infectious Disease Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Anti-infectious Disease Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Anti-infectious Disease Drugs Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Anti-infectious Disease Drugs Product Type
Table 9. List of Global Tier 1 Anti-infectious Disease Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-infectious Disease Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Anti-infectious Disease Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Anti-infectious Disease Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Anti-infectious Disease Drugs Revenue (US$, Mn), 2023-2030
Table 14. By Type - Global Anti-infectious Disease Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Anti-infectious Disease Drugs Sales (K Units), 2023-2030
Table 16. By Application ? Global Anti-infectious Disease Drugs Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Anti-infectious Disease Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Anti-infectious Disease Drugs Revenue (US$, Mn), 2023-2030
Table 19. By Application - Global Anti-infectious Disease Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Anti-infectious Disease Drugs Sales (K Units), 2023-2030
Table 21. By Region ? Global Anti-infectious Disease Drugs Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Anti-infectious Disease Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Anti-infectious Disease Drugs Revenue (US$, Mn), 2023-2030
Table 24. By Region - Global Anti-infectious Disease Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Anti-infectious Disease Drugs Sales (K Units), 2023-2030
Table 26. By Country - North America Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Anti-infectious Disease Drugs Revenue, (US$, Mn), 2023-2030
Table 28. By Country - North America Anti-infectious Disease Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Anti-infectious Disease Drugs Sales, (K Units), 2023-2030
Table 30. By Country - Europe Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Anti-infectious Disease Drugs Revenue, (US$, Mn), 2023-2030
Table 32. By Country - Europe Anti-infectious Disease Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Anti-infectious Disease Drugs Sales, (K Units), 2023-2030
Table 34. By Region - Asia Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Anti-infectious Disease Drugs Revenue, (US$, Mn), 2023-2030
Table 36. By Region - Asia Anti-infectious Disease Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Anti-infectious Disease Drugs Sales, (K Units), 2023-2030
Table 38. By Country - South America Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Anti-infectious Disease Drugs Revenue, (US$, Mn), 2023-2030
Table 40. By Country - South America Anti-infectious Disease Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Anti-infectious Disease Drugs Sales, (K Units), 2023-2030
Table 42. By Country - Middle East & Africa Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Anti-infectious Disease Drugs Revenue, (US$, Mn), 2023-2030
Table 44. By Country - Middle East & Africa Anti-infectious Disease Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Anti-infectious Disease Drugs Sales, (K Units), 2023-2030
Table 46. Aridis Pharmaceuticals Corporate Summary
Table 47. Aridis Pharmaceuticals Anti-infectious Disease Drugs Product Offerings
Table 48. Aridis Pharmaceuticals Anti-infectious Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. AiCuris Corporate Summary
Table 50. AiCuris Anti-infectious Disease Drugs Product Offerings
Table 51. AiCuris Anti-infectious Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 52. Sandoz Corporate Summary
Table 53. Sandoz Anti-infectious Disease Drugs Product Offerings
Table 54. Sandoz Anti-infectious Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 55. Anhui Jingfang Medical Industry Co.,Ltd Corporate Summary
Table 56. Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Product Offerings
Table 57. Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 58. Beijing Double-Crane Pharmaceutical Co., Ltd. Corporate Summary
Table 59. Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Product Offerings
Table 60. Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Abbott Corporate Summary
Table 62. Abbott Anti-infectious Disease Drugs Product Offerings
Table 63. Abbott Anti-infectious Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 64. Spero Therapeutics Corporate Summary
Table 65. Spero Therapeutics Anti-infectious Disease Drugs Product Offerings
Table 66. Spero Therapeutics Anti-infectious Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 67. Adlyfe, Inc. Corporate Summary
Table 68. Adlyfe, Inc. Anti-infectious Disease Drugs Product Offerings
Table 69. Adlyfe, Inc. Anti-infectious Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 70. Advanced Life Sciences Holdings, Inc. Corporate Summary
Table 71. Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Product Offerings
Table 72. Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Affinium Pharmaceuticals Corporate Summary
Table 74. Affinium Pharmaceuticals Anti-infectious Disease Drugs Product Offerings
Table 75. Affinium Pharmaceuticals Anti-infectious Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 76. APP Pharmaceuticals Corporate Summary
Table 77. APP Pharmaceuticals Anti-infectious Disease Drugs Product Offerings
Table 78. APP Pharmaceuticals Anti-infectious Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 79. Aquapharm Biodiscovery Corporate Summary
Table 80. Aquapharm Biodiscovery Anti-infectious Disease Drugs Product Offerings
Table 81. Aquapharm Biodiscovery Anti-infectious Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 82. Basilea Pharmaceutica AG Corporate Summary
Table 83. Basilea Pharmaceutica AG Anti-infectious Disease Drugs Product Offerings
Table 84. Basilea Pharmaceutica AG Anti-infectious Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Biophage Pharma, Inc. Corporate Summary
Table 86. Biophage Pharma, Inc. Anti-infectious Disease Drugs Product Offerings
Table 87. Biophage Pharma, Inc. Anti-infectious Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 88. Anti-infectious Disease Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2023 (K Units)
Table 89. Global Anti-infectious Disease Drugs Capacity Market Share of Key Manufacturers, 2020-2023
Table 90. Global Anti-infectious Disease Drugs Production by Region, 2018-2023 (K Units)
Table 91. Global Anti-infectious Disease Drugs Production by Region, 2023-2030 (K Units)
Table 92. Anti-infectious Disease Drugs Market Opportunities & Trends in Global Market
Table 93. Anti-infectious Disease Drugs Market Drivers in Global Market
Table 94. Anti-infectious Disease Drugs Market Restraints in Global Market
Table 95. Anti-infectious Disease Drugs Raw Materials
Table 96. Anti-infectious Disease Drugs Raw Materials Suppliers in Global Market
Table 97. Typical Anti-infectious Disease Drugs Downstream
Table 98. Anti-infectious Disease Drugs Downstream Clients in Global Market
Table 99. Anti-infectious Disease Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anti-infectious Disease Drugs Segment by Type
Figure 2. Anti-infectious Disease Drugs Segment by Application
Figure 3. Global Anti-infectious Disease Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti-infectious Disease Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Anti-infectious Disease Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. Anti-infectious Disease Drugs Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anti-infectious Disease Drugs Revenue in 2022
Figure 9. By Type - Global Anti-infectious Disease Drugs Sales Market Share, 2018-2030
Figure 10. By Type - Global Anti-infectious Disease Drugs Revenue Market Share, 2018-2030
Figure 11. By Type - Global Anti-infectious Disease Drugs Price (US$/Unit), 2018-2030
Figure 12. By Application - Global Anti-infectious Disease Drugs Sales Market Share, 2018-2030
Figure 13. By Application - Global Anti-infectious Disease Drugs Revenue Market Share, 2018-2030
Figure 14. By Application - Global Anti-infectious Disease Drugs Price (US$/Unit), 2018-2030
Figure 15. By Region - Global Anti-infectious Disease Drugs Sales Market Share, 2018-2030
Figure 16. By Region - Global Anti-infectious Disease Drugs Revenue Market Share, 2018-2030
Figure 17. By Country - North America Anti-infectious Disease Drugs Revenue Market Share, 2018-2030
Figure 18. By Country - North America Anti-infectious Disease Drugs Sales Market Share, 2018-2030
Figure 19. US Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 20. Canada Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. Mexico Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. By Country - Europe Anti-infectious Disease Drugs Revenue Market Share, 2018-2030
Figure 23. By Country - Europe Anti-infectious Disease Drugs Sales Market Share, 2018-2030
Figure 24. Germany Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. France Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. U.K. Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. Italy Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 28. Russia Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Nordic Countries Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. Benelux Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. By Region - Asia Anti-infectious Disease Drugs Revenue Market Share, 2018-2030
Figure 32. By Region - Asia Anti-infectious Disease Drugs Sales Market Share, 2018-2030
Figure 33. China Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 34. Japan Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. South Korea Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. Southeast Asia Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 37. India Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. By Country - South America Anti-infectious Disease Drugs Revenue Market Share, 2018-2030
Figure 39. By Country - South America Anti-infectious Disease Drugs Sales Market Share, 2018-2030
Figure 40. Brazil Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Argentina Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - Middle East & Africa Anti-infectious Disease Drugs Revenue Market Share, 2018-2030
Figure 43. By Country - Middle East & Africa Anti-infectious Disease Drugs Sales Market Share, 2018-2030
Figure 44. Turkey Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 45. Israel Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 46. Saudi Arabia Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 47. UAE Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 48. Global Anti-infectious Disease Drugs Production Capacity (K Units), 2018-2030
Figure 49. The Percentage of Production Anti-infectious Disease Drugs by Region, 2022 VS 2030
Figure 50. Anti-infectious Disease Drugs Industry Value Chain
Figure 51. Marketing Channels
